Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Novartis MenB Vaccine +/- OMV in Infants
NCT00433914Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2007
- Primary completion
- Dec 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Multicomponent meningococcal B vaccine in meningococcal disease, sponsored by Novartis. Started Feb 2007; status: completed.
02
Drugs
Multicomponent meningococcal B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00433914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433914.